{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:54:04Z","timestamp":1781592844318,"version":"3.54.5"},"reference-count":31,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Purpose: Adjuvant radiotherapy (RT) for ductal carcinoma in situ (DCIS) remains a widely discussed topic. While it has been shown to significantly reduce recurrence rates, it does not improve overall survival (OS) and may therefore lead to overtreatment in some cases. This study aimed to assess patient acceptance, quality of life (QoL), and decisional regret (DR) in relation to late adverse effects. Methods: Clinical data from patients who underwent RT for DCIS between 2008 and 2020 were retrospectively collected, while follow-up questionnaires evaluated QoL and DR. High-risk DCIS was defined as tumor size \u2265 2.5 cm, poor differentiation (G3), age \u2264 50, and symptomatic diagnosis. Low-risk disease was defined as tumor size &lt; 2 cm, G1\/G2, age &gt; 50, and mammographic diagnosis. Patients who did not meet all criteria for either category were classified as intermediate risk, therefore reflecting everyday work and clinical practice. Questionnaire data were analyzed using both scale-level and item-level approaches and Ipsilateral breast recurrence-free survival (IBRFS) rates were calculated using the Kaplan\u2013Meier method. Results: Among 307 cases offered RT, only 24 declined, indicating high treatment acceptance; an additional 20 cases lacked sufficient documentation, did not receive RT at our center despite acceptance, or discontinued RT prematurely. During the study period, late toxicities occurred at acceptable frequencies: fibrosis in 6.1%, hyperpigmentation in 6.8%, telangiectasia in 8%, and edema in 1.5% of cases with excellent control rates of 90.0%. The response rate to the EORTC QLQ-C30 and Ottawa Decisional Regret Scale (DRS) was 35.4%, of whom 70 cases belonged to the intermediate-risk group. These respondents reported high QoL and low levels of DR. Conclusions: RT for intermediate grade DCIS is accepted and tolerated well, and neither late adverse effects nor QoL outcomes were associated with DR. These findings support recommending RT in this borderline-indication group.<\/jats:p>","DOI":"10.3390\/cancers18121946","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:46:28Z","timestamp":1781588788000},"page":"1946","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiotherapy for Ductal Carcinoma In Situ: Toxicity, Quality of Life, and Decisional Regret at a Tertiary Cancer Center"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9022-6411","authenticated-orcid":false,"given":"Husam Abdulsattar","family":"Alhasan","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus Anton","family":"Schirmer","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5378-4246","authenticated-orcid":false,"given":"Leif Hendrik","family":"Dr\u00f6ge","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"},{"name":"Comprehensive Cancer Center G\u00f6ttingen (G-CCC), University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9620-8601","authenticated-orcid":false,"given":"Carla Marie","family":"Zwerenz","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"},{"name":"Comprehensive Cancer Center G\u00f6ttingen (G-CCC), University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2599-6196","authenticated-orcid":false,"given":"Manuel","family":"Guhlich","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"},{"name":"Comprehensive Cancer Center G\u00f6ttingen (G-CCC), University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Donath","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"},{"name":"Comprehensive Cancer Center G\u00f6ttingen (G-CCC), University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7018-2856","authenticated-orcid":false,"given":"Stefan","family":"Rieken","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"},{"name":"Comprehensive Cancer Center G\u00f6ttingen (G-CCC), University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0935-1208","authenticated-orcid":false,"given":"Gunther","family":"Felmerer","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center G\u00f6ttingen (G-CCC), University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"},{"name":"Department for Trauma Surgery, Orthopedics and Plastic Surgery, Division of Plastic Surgery, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6562-6616","authenticated-orcid":false,"given":"Stephanie","family":"Bendrich","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"},{"name":"Comprehensive Cancer Center G\u00f6ttingen (G-CCC), University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/his.14804","article-title":"Identifying recurrences and metastasis after ductal carcinoma In Situ (DCIS) of the breast","volume":"82","author":"Udayasiri","year":"2023","journal-title":"Histopathology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1055\/a-2505-1682","article-title":"Treatment and Outcome of Ductal Carcinoma in Situ for the German Federal States Berlin and Brandenburg in the Period 2007\u20132020","volume":"85","author":"Burmeister","year":"2025","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13058-025-02068-9","article-title":"Trends in breast cancer death rates from ductal carcinoma in situ versus invasive cancer in the United States","volume":"27","author":"Sung","year":"2025","journal-title":"Breast Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e2017124","DOI":"10.1001\/jamanetworkopen.2020.17124","article-title":"Association of a Diagnosis of Ductal Carcinoma In Situ with Death from Breast Cancer","volume":"3","author":"Giannakeas","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"102223","DOI":"10.1016\/j.suronc.2025.102223","article-title":"A systematic review on the management of ductal carcinoma in situ of the breast","volume":"60","author":"Brackstone","year":"2025","journal-title":"Surg. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/0284186X.2023.2245552","article-title":"Outcome of different radiotherapy strategies after breast conserving surgery in patients with ductal carcinoma In Situ (DCIS)","volume":"62","author":"Wadsten","year":"2023","journal-title":"Acta Oncol."},{"key":"ref_8","unstructured":"Onkologie.de (2026, March 15). Leitlinien Onkologie. Available online: https:\/\/hub.leitlinienprogramm-onkologie.de\/leitlinie\/frueherkennung-diagnostik-therapie-und-nachsorge-des-mammakarzinoms."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jjco\/hyae122","article-title":"Update on the management of ductal carcinoma in situ of the breast: Current approach and future perspectives","volume":"55","author":"Kanbayashi","year":"2024","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3348\/kjr.2009.10.5.496","article-title":"Radiation-Induced Complications after Breast Cancer Radiation Therapy: A Pictorial Review of Multimodality Imaging Findings","volume":"10","author":"Yi","year":"2009","journal-title":"Korean J. Radiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1245\/s10434-013-3176-2","article-title":"DCIS Treated with Excision Alone Using the National Comprehensive Cancer Network (NCCN) Guidelines","volume":"20","author":"Wehner","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1200\/JCO.21.01083","article-title":"Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report from NRG Oncology\/RTOG 9804","volume":"39","author":"McCormick","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000545019","article-title":"AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025","volume":"20","author":"Albert","year":"2025","journal-title":"Breast Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejso.2013.12.013","article-title":"The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast","volume":"40","author":"Barnes","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_15","unstructured":"National Cancer Institute (2026, March 15). Resources for Researchers: Common Terminology Criteria for Adverse Events (CTCAE), Available online: https:\/\/www.cancer.gov\/research\/resources."},{"key":"ref_16","unstructured":"Fayers, P.M., Aaronson, N.K., Bjordal, K., Groenvold, M., Curran, D., Bottomley, A., and on behalf of the EORTC Quality of Life Group (2001). The EORTC QLQ-C30 Scoring Manual, European Organisation for Research and Treatment of Cancer. [3rd ed.]."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00432-024-05638-0","article-title":"Decision regret of cancer patients after radiotherapy: Results from a cross-sectional observational study at a large tertiary cancer center in Germany","volume":"150","author":"Wieland","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Gross, A., Ziepert, M., and Scholz, M. (2012). KMWin\u2014A Convenient Tool for Graphical Presentation of Results from Kaplan-Meier Survival Time Analysis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038960"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0272989X03256005","article-title":"Validation of a decision regret scale","volume":"23","author":"Brehaut","year":"2003","journal-title":"Med. Decis. Mak."},{"key":"ref_21","unstructured":"O\u2019Connor, A.M. (1996). User Manual\u2014Decision Regret Scale [Document on the Internet], Ottawa Hospital Research Institute. Available online: https:\/\/decisionaid.ohri.ca\/docs\/develop\/User_manuals\/UM_Regret_Scale.pdf."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","article-title":"Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial","volume":"32","author":"Garmo","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0959-8049(97)00137-8","article-title":"Ten-year results of treatment of ductal carcinoma In Situ (DCIS) of the breast with conservative surgery and radiotherapy","volume":"33","author":"Amichetti","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"k1410","DOI":"10.1136\/bmj.k1410","article-title":"Should patients with ductal carcinoma in situ be treated with adjuvant whole breast radiotherapy after breast conservation surgery?","volume":"361","author":"Bagenal","year":"2018","journal-title":"BMJ"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","article-title":"Breast-Conserving Treatment with or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, from the EORTC 10853 Randomized Phase III Trial","volume":"31","author":"Donker","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/modpathol.2014.141","article-title":"Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up","volume":"28","author":"Sanders","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.2010.34.0141","article-title":"Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women with Estrogen Receptor\u2013Positive Ductal Carcinoma In Situ: A Study Based on NSABP Protocol B-24","volume":"30","author":"Allred","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2025.07.1442","article-title":"Late Toxicities and Quality of Life After a Radiation Boost for Breast Ductal Carcinoma In Situ: Boost or No Boost in DCIS Randomized Trial","volume":"124","author":"Bourgier","year":"2026","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nrc1950","article-title":"Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology","volume":"6","author":"Bentzen","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.clbc.2025.11.001","article-title":"Quality of Life and Fear of Recurrence or Progression in Women with DCIS Who Did and Did Not Receive Radiotherapy","volume":"26","author":"Sinclair","year":"2025","journal-title":"Clin. Breast Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/12\/1946\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:19:12Z","timestamp":1781590752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/12\/1946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["cancers18121946"],"URL":"https:\/\/doi.org\/10.3390\/cancers18121946","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}